Home > Boards > US Listed > Medical - Drugs > Altimmune, Inc (ALT)

Catchmeifyoucan, I think I remember you from this

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
lumpy9200 Member Profile
Member Level 
Followed By 39
Posts 2,050
Boards Moderated 0
Alias Born 05/21/06
160x600 placeholder
Altimmune to Announce First Quarter 2021 Financial Results on May 17, 2021 GlobeNewswire Inc. - 5/11/2021 7:00:00 AM
Altimmune reports encouraging AdCOVID data in SARS-CoV-2 challenged mice Seeking Alpha - 5/10/2021 9:41:29 AM
Altimmune Announces New Preclinical Data for AdCOVID™ Demonstrating Sterilizing Immunity After a Single Intranasal Dose GlobeNewswire Inc. - 5/10/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/4/2021 7:01:06 PM
Altimmune to Present at Upcoming Scientific Conferences GlobeNewswire Inc. - 4/29/2021 7:00:00 AM
Altimmune highlights safety of anthrax vaccine candidate with early-stage results Seeking Alpha - 4/1/2021 3:16:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2021 7:31:32 AM
Altimmune Reports Data from its Phase 1b Clinical Trial of NasoShield™ GlobeNewswire Inc. - 4/1/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/31/2021 7:01:25 PM
AstraZeneca’s foray into COVID-19 nasal spray sparks interest in Altimmune Seeking Alpha - 3/26/2021 1:45:41 PM
Altimmune Partners with Summit Biosciences to Produce a Multidose Nasal Spray Presentation of its AdCOVID™ Vaccine Candidat... GlobeNewswire Inc. - 3/22/2021 7:00:00 AM
Altimmune shares rise 11% as COVID-19 vaccine prevents infection, reduces virus replication Seeking Alpha - 3/15/2021 8:33:26 AM
AdCOVID™, Altimmune’s Single Dose, Intranasal COVID-19 Vaccine Candidate, Prevents SARS-CoV-2-induced Disease and Blocks ... GlobeNewswire Inc. - 3/15/2021 7:00:00 AM
Altimmune Extends Lonza Partnership To Support Production Of AdCOVID TipRanks - 3/14/2021 5:18:08 AM
Altimmune Expands Manufacturing Agreement for Covid-19 Vaccine Candidate Dow Jones News - 3/12/2021 6:44:00 AM
Altimmune expands AdCOVID manufacturing pact with Lonza Seeking Alpha - 3/12/2021 3:18:43 AM
Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza GlobeNewswire Inc. - 3/12/2021 1:00:00 AM
Altimmune to Present at Upcoming Conferences GlobeNewswire Inc. - 3/8/2021 4:01:00 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/1/2021 4:09:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/1/2021 4:04:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/25/2021 4:06:55 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/25/2021 8:19:57 AM
Altimmune EPS beats by $0.68, beats on revenue Seeking Alpha - 2/25/2021 7:19:23 AM
Annual Report (10-k) Edgar (US Regulatory) - 2/25/2021 7:12:23 AM
Altimmune starts enrollment in phase 1 COVID-19 trial of Adcovid Seeking Alpha - 2/25/2021 7:10:04 AM
lumpy9200 Member Level  Saturday, 03/27/21 01:03:46 PM
Re: catchmeifyoucan post# 1485
Post # of 1487 
Catchmeifyoucan, I think I remember you from this board, long ago when I used to post on iHub (just getting back to it after a long break). I've been holding ALT for ages, based originally on the hope for an intranasal flu vaccine. As good as I think that may yet be, an intranasal covid vaccine that doesn't need to be stored at ultra freezing temperatures is an absolute game changer. So far, so good with all the pre-clinical data. If this comes good, I think we have an absolute monster on our hands. No needles, no cold temps, and easy to transport and deliver to parts of the world where things are a little less modernized than here, Europe, etc. Life changing gains for ALT shareholders if AdCovid makes it through clinical trials. I've actually added more here in the $13s, even though I have so many shares from $1.50-2.50 range.

Best to you and all ALT longs

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences